Press release from Companies: DBP International AB: Named Patient Early Access Program with Temozolomide gel (Temodex®) has been launched

Press release from Companies: DBP International AB: Named Patient Early Access-programmet för Temozolomid gel (Temodex®) är i gång

Press release from Companies: DBP International: 20% of the shares of Bio Vitos is received

Press release from Companies: DBP International AB: 20% av aktierna i Bio Vitos erhölls

Press release from Companies: Rättelse: Kvartalsrapport tre - 2021

Reports: Kvartalsrapport tre - 2021

Press release from Companies: DBP International AB has together with Bio Vitos Medical Ltd signed an agreement on scientific, technical and sales collaboration with Belarusian Academpharm

Press release from Companies: DBP International AB tillsammans med Bio Vitos Medical Ltd signerar avtal om ett vetenskapligt, tekniskt och försäljningsmässigt samarbete med belarusiska Academpharm

Press release from Companies: DBP International: Signed a collaboration partnership agreement with Alexavi for commercialization of Temodex®

Press release from Companies: DBP International har tecknat ett samarbetsavtal med Alexavi kring marknadsföring av Temodex®

Press release from Companies: Komplettering: DBP International AB: licensierar ut rättigheterna till internationellt patent för användning av järnsuccinat till YRRO

Press release from Companies: DBP International: Out-licensing to YRRO rights for an international patent for the use of ferrous succinate